TNYA - Tenaya Therapeutics, Inc.

Across the last three months, Tenaya Therapeutics, Inc.'s insiders have reduced their positions by a net 29,656 shares worth roughly $21K.

TNYA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Ali Faraz	539.8K	-	-
Other	Tingley Whittemore	263.1K	-	-
VP	Higa Tomohiro	118.3K	$93.8K	-
10%	Column Group III Gp, LP	0	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 10, 2025	Tingley Whittemore66	Chief Medical Officer	Sell	7,398	$0.54	$3,983.08	-4.1%	+35.5%	+77.0%
Mar 10, 2025	Higa Tomohiro	SVP, Finance	Sell	2,482	$0.54	$1,336.31	-2.4%	+35.5%	+77.0%
Mar 10, 2025	Ali Faraz66	Chief Executive Officer	Sell	9,741	$0.54	$5,244.55	-2.9%	+35.5%	+77.0%
Mar 5, 2025	Column Group III Gp, LP74	10% Owner	Buy	35,714,284	$0.70	$24,999,998.80	+262.6%	+7.7%	+80.1%
Mar 5, 2025	Goeddel David V71	Director, 10% Owner	Buy	35,714,284	$0.70	$24,999,998.80	+262.6%	+7.7%	+80.1%
Nov 18, 2024	Saito Chihiro	SVP, Accounting and Fin. Ops.	Sell	2,258	$2.12	$4,786.96	-3.6%	-44.7%	-37.9%
Aug 16, 2024	Tingley Whittemore66	Chief Medical Officer	Sell	7,428	$2.89	$21,500.35	-6.5%	-30.1%	-59.9%
Aug 16, 2024	Ali Faraz66	Chief Executive Officer	Sell	9,748	$2.89	$28,215.59	-4.9%	-30.1%	-59.9%
Aug 16, 2024	Saito Chihiro	SVP, Accounting and Fin. Ops.	Sell	2,363	$2.89	$6,839.70	-3.6%	-30.1%	-59.9%
Mar 5, 2024	Hoey Timothy82	Chief Scientific Officer	Sell10b5-1	3,300	$7.00	$23,100.99	-1.3%	-41.5%	-93.3%